ÂÜÀòÂÒÂ×

Cherry T. Thomas, M.D., is the Chief Medical Officer at Wugen, bringing extensive expertise as an Oncologist in the pharma and biotech industry. They previously held senior roles at Caribou Biosciences, Amgen, Novartis, Bristol-Myers Squibb, and BeiGene, where they led clinical development and regulatory strategies for various oncology therapies. Cherry has established and directed clinical teams, successfully executed first-in-human trials, and maintained strong relationships with clinical leaders in oncology research. They continue to advance their education with ongoing studies at multiple institutions, including the University of Michigan and UCLA.